Emerald Clinical

Global CRO | 25+ yrs in clinical trials | 800+ experts | 40+ countries | Biotech & top pharma partners | Renal, Oncology, Autoimmune & more

[Emerald Clinical @emeraldclinical]

Wishing everyone a reflective and hopeful Matariki. May this Māori New Year bring renewal, connection, and new beginnings for you and your communities.

#Matariki #NewBeginnings #Community #Reflection #Aotearoa

[Emerald Clinical @emeraldclinical]

Join Emerald Clinical Trials and build a career that truly matters — impact global health and grow with a team dedicated to excellence in clinical research.

Ready to make a difference? Explore open roles and apply today: https://t.co/DjFnYf058N

#Careers #ClinicalResearch #JoinOurTeam #LifeSciences #EmeraldClinical

[Emerald Clinical @emeraldclinical]

From July 15 to 19, 2026, BIO Asia–Taiwan 2026 will be held at the Taipei Nangang Exhibition Center! Under the theme “Asian Inspiration, Global Impact” to explore innovation trends and collaboration opportunities in APAC.

Emerald Clinical will be showcasing at Australia Pavilion (Booth M704), offering you specialized clinical trial services, including:

• Clinical Trial Management
• Regulatory Consulting
• Medical Writing
• Data Management and Biostatistics

We invite you to visit us at Booth M704 to speak with our team!

Learn more about Emerald Clinical - https://t.co/J7VQxYc16W https://t.co/0qiZvL0DDR

#ScienceSpeedService #ClinicalTrials #ImprovingLivesWorldwide #APAC #BioAsiaTaiwan

[Emerald Clinical @emeraldclinical]

Clinical trials are complex. Your CRO shouldn’t be.

At Emerald Clinical, we bring together science, speed, and strategy to deliver smarter trials and stronger outcomes — across Renal, Oncology, Cardiometabolic, and more.

✔ Global reach with deep APAC expertise
✔ End-to-end clinical trial solutions
✔ Proven partnerships with leading biotech and pharma

Let’s turn complexity into clarity.

👉 Discover how we can support your next trial. Contact us for an initial consultation. https://t.co/8oR3S6P6Mj

#ScienceServiceSolutions #Speed #Strategy #ClinicalTrials #ImprovingLivesWorldwide

[Emerald Clinical @emeraldclinical]

Happy 4th of July!

Wishing our US colleagues, partners and communities a safe and joyful Independence Day.

[Emerald Clinical @emeraldclinical]

Emerald Clinical successfully delivered China’s first oncology FSMP trial, enrolling patients in two years despite COVID-19.

Regulatory expertise, strong communication, and flexible operations enabled smooth site start-up, patient recruitment, and high-quality data collection. Our full-service approach—from protocol development to site management and patient support—ensured this groundbreaking trial met global program standards.

Discover how we turn complex trials into success stories.

Read the full case study here - https://t.co/HLu5uSCzht

#ClinicalResearch #Oncology #FSMP #GlobalTrials #PatientCentric #EmeraldClinical

[Emerald Clinical @emeraldclinical]

More than a CRO. A true scientific partner.

At Emerald Clinical, we combine deep scientific expertise with global execution to accelerate smarter clinical development — from early phase to real-world studies.

With strong roots in APAC and a global footprint, we help sponsors navigate complexity, recruit faster, and deliver high-quality outcomes across every phase.

Ready to advance your next study? Contact us for an initial consultation.

👉 Explore Emerald Clinical - - https://t.co/rS53hy0TxS

#ClinicalResearch #DrugDevelopment #ClinicalTrials #CROpartner #LifeSciences

[Emerald Clinical @emeraldclinical]

Check out our latest article by our CFO, Tony Proctor.

China’s biotech surge is reshaping the global life‑sciences landscape — a must-read analysis from our CFO on what this means for innovation, investment, and clinical development: https://t.co/rIljT6TqXM

Read, share, and tell us: how will your organization adapt?

#Biotech #China #LifeSciences #ClinicalTrials #Pharma #HealthcareInnovation #BiotechInvestment #GlobalHealth #CFOInsights #DrugDevelopment

[Emerald Clinical @emeraldclinical]

What Sponsors Must Do Next to Win in Rare Renal Disease

For years, diseases like IgAN, FSGS, and C3G were seen as too complex, too slow, and too risky. Today, that’s changed—driven by regulatory innovation, new endpoints, and a rapidly expanding pipeline.

But winning in this space requires a shift in approach:
🔹 Move beyond “one-size-fits-all” trial designs
🔹 Embrace biomarker-driven strategies and disease subtyping
🔹 Align endpoints with disease biology
🔹 Design globally integrated, agile trials from the outset

As the science evolves, so must development strategy.

👉 Read the full article https://t.co/zgGCR59vX8

#Nephrology #RareDisease #ClinicalTrials #DrugDevelopment #Biotech #Renal

[Emerald Clinical @emeraldclinical]

In renal drug development, strategy alone isn’t enough—execution is everything.
At Emerald Clinical, risk reduction comes from combining:

✔️ Experienced renal KOLs with real-world clinical insight
✔️ Dedicated operational teams with a proven delivery track record

This integrated model gives you a clear view of how protocol design, geography, patient population, and competition will impact timelines, costs, and outcomes—before it’s too late

With deep global site relationships and renal expertise across 70+ countries, we help you:
• Accelerate recruitment and improve retention
• Select the right locations and patient populations
• Deliver studies efficiently and in line with regulatory expectations

Because in renal, success isn’t just about good design—
it’s about delivering it flawlessly.

https://t.co/HUU46ssNeS

#ClinicalTrials #RenalResearch #DrugDevelopment #Biotech #Pharma

[Emerald Clinical @emeraldclinical]

There’s still time — Maha Rinaudo is at BIO International. Reach out to her on LinkedIn to schedule a time to discuss how we can help accelerate your PoC studies!

Learn more about how Emerald Clinical can accelerate your programme. https://t.co/E3xbYgWWeE

#BIO2026 #ProofOfConcept #ClinicalTrials #EmeraldClinical

[Emerald Clinical @emeraldclinical]

Renal drug development is evolving—fast.

Success today demands deeper clinical insight, smarter trial design, and global execution that delivers results earlier.

At Emerald Clinical, we combine world leading nephrology expertise with global CRO capabilities to accelerate renal trials—from protocol design to clinical conclusions. [https://t.co/2M5WllkcIB]

The result? Faster start up, stronger patient recruitment, and high quality data that moves therapies forward with confidence. [https://t.co/2M5WllkcIB]

👉 Explore our renal CRO expertise https://t.co/7CrtEJUBHT

#Renal #Nephrology #ClinicalTrials #Biotech #DrugDevelopment #CRO

[Emerald Clinical @emeraldclinical]

Speed matters in oncology—but so does getting the right data, early.
At Emerald Clinical, we accelerate proof of concept through a globally integrated model—spanning the US, Europe, Australia, and China—delivering faster start up, quicker enrolment, and earlier decision making.

From FIH to early readouts, we help biotechs reduce risk and move forward with confidence.
👉 Explore our accelerated oncology approach https://t.co/Z30oQipnal

#Oncology #ClinicalTrials #Biotech #DrugDevelopment #CRO #EarlyPhase

[Emerald Clinical @emeraldclinical]

Accelerating Oncology Proof of Concept isn’t just about speed—it’s about smarter, global design.

From First in Human to early readouts, our integrated model spans the US, Europe, Australia, and China—delivering faster data, earlier decisions, and reduced development risk.

Explore how we accelerate Oncology PoC
https://t.co/Z30oQipnal

#Oncology #ClinicalTrials #DrugDevelopment #Biotech #EarlyPhase #CRO

Vice President, Global Head of Oncology
Scientific and Medical Affairs

[Emerald Clinical @emeraldclinical]

Accelerating oncology proof of concept isn’t just about speed—it’s about smarter, global design.

From First in Human to early readouts, our integrated model spans the US, Europe, Australia, and China—delivering faster data, earlier decisions, and reduced development risk.

Explore how we accelerate oncology PoC
https://t.co/E3xbYgWWeE

#Oncology #ClinicalTrials #DrugDevelopment #Biotech #EarlyPhase #CRO

[Emerald Clinical @emeraldclinical]

Fresh insights from ERA: our team returned with practical learnings on trial design, patient engagement, and biomarker endotyping that will sharpen renal programs and speed development. As the leading CRO in renal research, we’re ready to put these advances into action with partners worldwide.

Read more about how we can help you with your renal trials - https://t.co/r4hRwrQvxw

#Nephrology #RenalResearch #ClinicalTrials #Biomarkers #PatientEngagement #CRO

[Emerald Clinical @emeraldclinical]

Evidence from ASCO 2025–2026 highlights a clear shift in global oncology.

China is moving rapidly from a proof-of-concept market to a pathway for global registration, with increasing alignment to FDA standards and accelerating timelines for innovative therapies.

As the science advances globally, the ability to execute trials at scale — across regions — is becoming a critical differentiator.

This is where Emerald Clinical can support to move your China strategy forward faster.

Contact our VP, Global Head Oncology Luke Gill

Read our ASCO key learnings here - https://t.co/DQkRce966M

#ASCO26 #Oncology #ClinicalTrials #China #Biotech

[Emerald Clinical @emeraldclinical]

Happy Dragon Boat Festival! 🐉

From racing dragon boats and sharing zongzi to hanging mugwort and calamus, these traditions bring us together—reminding us to listen, learn, and lead as one. Wishing our teams and partners worldwide a safe, healthy, and peaceful celebration.

#DragonBoatFestival #CulturalHeritage #CommunityCelebration

[Emerald Clinical @emeraldclinical]

Renal drug development is one of the most complex—and competitive—spaces in pharma today.
Getting it right early isn’t just important… it’s critical.

Our Renal Advisory Board helps you:
✔️ Anticipate risks before they become costly setbacks
✔️ Define the right endpoints, population, and dosing
✔️ Build a data package aligned to approval and patient access

Backed by a proven renal track record, global KOL relationships, and 90+ experts across clinical practice and development—we bring the insight needed to turn strategy into success.
Because in renal, it’s not just about moving forward—it’s about moving forward with confidence.

https://t.co/HUU46ssNeS

#ClinicalTrials #RenalResearch #DrugDevelopment #Biotech #Pharma

[Emerald Clinical @emeraldclinical]

Maha Rinaludo will be attending BIO International — book a time to meet and discuss how Emerald Clinical can accelerate your programs.

In the meantime, learn more: https://t.co/vHnYQz6WB8

#BIO2026 #Biotech #ClinicalTrials #Partnerships #EmeraldClinical